Respi4Doctors est une plate-forme numérique via laquelle AstraZeneca offre des informations et des services en rapport avec le traitement des troubles respiratoires.

Impact of treatment with aclidinium/formoterol on physical activity

Regular physical activity decreases the risk of mortality and hospital admissions among COPD patients1. Hence, maintaining or increasing physical activity is a key objective of COPD management2.

A recent study evaluated the impact of treatment with aclidinium/formoterol on physical activity3. This slide kit provides more details on this recent publication in the International Journal of COPD.

References:

1.    Garcia-Aymerich et al., Thorax. 2006; 61: 772-778  -  2. GOLD, Edition 2014  -  3. Watz et al., Int J of COPD. 2017; 12: 2545-58

Preview

Scroll here